|
Our valuation experience includes:
- Valuations of businesses across industries as diverse as health and aged care, media, chemicals, industrial manufacturing, construction, biotech, retail, professional services, agricultural production and services, wholesale and distribution and financial services / mortgage providers.
- Valuing Australian listed healthcare companies: CSL, Cochlear, Sonic Healthcare, ResMed, Symbion Health, Mayne Pharma, Healthscope, Ramsay Healthcare, Ansell, DCA Group.
- Building forecast models for the Australian diagnostics (pathology and radiology) market.
- Forecasting CSL's likely worldwide royalties for a new cervical cancer vaccine.
- Modelling of the global hearing impaired market.
- Valuation models of News Corp’s Australian and UK newspaper assets (including The Times (UK), The Sun (UK), The Herald-Sun (Aust), The Australian) including modelling of the newspaper advertising market in both countries.
- Modelling of the US film/DVD market, including the profitability modelling of a “typical” feature film.
- Valuation modelling of News Corp’s Asian (principally in India and China) pay-TV operations (STAR).
- Diversified chemicals company Orica Ltd, including valuation modelling of its listed (now spun out) fertiliser manufacturing subsidiary Incitec Pivot Ltd.
- Global agricultural companies including: Monsanto, Syngenta, Cargill.
- Global mining companies including: Phelps Dodge, Xstrata, Inco.
- UK support services companies including Serco, Rentokil-Initial and Capita.
- European pay-TV companies including BSkyB, ntl, Telewest.
|